Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-02-11 | 2022-02-18 | 154749 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2022-10-28 | 2022-11-11 | 172960 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177132 |
| APO-AMOXI CLAV | 250MG 125MG | TABLET | Resolved | 2020-01-15 | 2020-02-19 | 103357 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-01-26 | 2024-03-01 | 217490 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223046 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223052 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-09-22 | 2023-12-08 | 204990 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-09-28 | 2023-10-06 | 205483 |
| APO-AMOXI CLAV | 400MG 57MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-18 | 41 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185039 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185483 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Resolved | 2025-02-20 | 2025-02-28 | 250941 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Actual shortage | 2025-03-20 | 2025-03-20 | 253070 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2019-06-19 | 2019-09-23 | 87057 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2018-09-09 | 44 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-13 | 49 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 636 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2017-06-05 | 2017-09-05 | 11959 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2018-02-05 | 2018-04-18 | 38473 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TICAGRELOR | 60MG | TABLET | To be discontinued | 2025-11-12 | 2025-11-20 | 257700 |
| APO-TICAGRELOR | 60MG | TABLET | Discontinued | 2025-11-19 | 2025-11-20 | 257747 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 |